Inovio Pharmaceuticals, Inc. Class Action Lawsuit
Company: Inovio Pharmaceuticals, Inc.
Ticker: (NASDAQ) INO
Class Action Period: October 10, 2023 - December 26, 2025
See If You Qualify For Monetary Reward
Join the Inovio Pharmaceuticals, Inc. Class Action Lawsuit
CLASS ACTION PERIOD
October 10, 2023 - December 26, 2025
Allegations
The complaint filed against Inovio Pharmaceuticals, Inc. alleges the company made statements that were materially false and/or misleading and/or failed to disclose that: (i) manufacturing for Inovio’s CELLECTRA device was deficient; (ii) accordingly, Inovio was unlikely to submit it's lead product candidate, INO-3107 BLA to the FDA by the second half of 2024; (iii) Inovio had insufficient information to justify the INO-3107 BLA’s eligibility for FDA accelerated approval or priority review; (iv) accordingly, INO-3107’s overall regulatory and commercial prospects were overstated; and (v) as a result, defendants’ public statements were materially false and misleading at all relevant times.
Eligibility
To join the lawsuit, you must have experienced a loss on Inovio Pharmaceuticals, Inc. shares purchased within the class period specified above.
Lead Plaintiff Deadline
If you suffered a loss in Inovio Pharmaceuticals, Inc. during the relevant time frame, you have until April 7, 2026 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
EXPLORE MORE CASES
REGENXBIO Inc.
RGNX
Lead Plaintiff Deadline: April 14, 2026
Class Period: February 9, 2022 - January 27, 2026
Ultragenyx Pharmaceutical Inc.
RARE
Lead Plaintiff Deadline: April 6, 2026
Class Period: August 3, 2023 - December 26, 2025